Follow The Filings

TOVX Theriva Biologics

Theriva Biologics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
8-K 5.02,5.07,9.01
8-K 7.01,8.01,9.01
DEF 14A
8-K 7.01,8.01,9.01
8-K 8.01
8-K 2.02,9.01
10-Q
DEF 14A
8-K 7.01,8.01,9.01
8-K 8.01
8-K 7.01,8.01,9.01
DEF 14A
8-K 2.02,9.01
10-K
8-K 1.01,7.01,9.01
8-K 8.01
8-K 8.01,9.01
DEF 14A
8-K 7.01,8.01,9.01
8-K 8.01
424B5

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jan 5, 2026 (4 forms)

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.